Education
About Us
Working with TipRanks
Follow Us
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
SUVENPHAR Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹921.50 - ₹1,359.00
Previous CloseN/A
Volume97.13K
Average Volume (3M)7.95K
Market Cap
₹367.65B
Enterprise Value₹294.79B
Total Cash (Recent Filing)₹6.56B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)88.9
Beta0.74
Next Earnings
Aug 13, 2025EPS Estimate
1.59Last Dividend Ex-Date
Sep 09, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)3.50
Shares Outstanding382,567,140
10 Day Avg. Volume4,490
30 Day Avg. Volume7,946
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,416.67Price Target Upside47.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering0
Suven Pharmaceuticals Ltd. News
SUVENPHAR FAQ
What was Suven Pharmaceuticals Ltd.’s price range in the past 12 months?
Suven Pharmaceuticals Ltd. lowest stock price was ₹921.50 and its highest was ₹1359.00 in the past 12 months.
What is Suven Pharmaceuticals Ltd.’s market cap?
Suven Pharmaceuticals Ltd.’s market cap is ₹367.65B.
When is Suven Pharmaceuticals Ltd.’s upcoming earnings report date?
Suven Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 13, 2025 which is in 5 days.
How were Suven Pharmaceuticals Ltd.’s earnings last quarter?
Suven Pharmaceuticals Ltd. released its earnings results on May 28, 2025. The company reported ₹3.5 earnings per share for the quarter, beating the consensus estimate of ₹3.4 by ₹0.1.
Is Suven Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Suven Pharmaceuticals Ltd.’s price is currently Undervalued.
Does Suven Pharmaceuticals Ltd. pay dividends?
Suven Pharmaceuticals Ltd. pays a Notavailable dividend of ₹5 which represents an annual dividend yield of N/A. See more information on Suven Pharmaceuticals Ltd. dividends here
What is Suven Pharmaceuticals Ltd.’s EPS estimate?
Suven Pharmaceuticals Ltd.’s EPS estimate is 1.59.
How many shares outstanding does Suven Pharmaceuticals Ltd. have?
Suven Pharmaceuticals Ltd. has 382,567,140 shares outstanding.
What happened to Suven Pharmaceuticals Ltd.’s price movement after its last earnings report?
Suven Pharmaceuticals Ltd. reported an EPS of ₹3.5 in its last earnings report, beating expectations of ₹3.4. Following the earnings report the stock price went up 1.382%.
Which hedge fund is a major shareholder of Suven Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:SUVENPHAR
Company Description
Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd. (SUVENPHAR) is an Indian pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company operates in the life sciences sector, focusing on the research and development of novel therapeutic molecules and formulations to address unmet medical needs. Suven Pharmaceuticals serves a global clientele, including top pharmaceutical companies, by providing contract research and manufacturing services (CRAMS) along with its own product portfolio.
Technical Analysis
Ajanta Pharma Limited
―
Biocon Limited
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―
Laurus Labs Ltd.
―